quinazolines has been researched along with 2,4,6-triamino-5-chloroquinazoline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukunaga, JY; Hansch, C; Steller, EE | 1 |
| Bird, K; Hunt, WE; Mallinson, PD; Schwalbe, CH | 1 |
| Avery, MA; Carvalho, P; Gibellini, F; Hunter, WN; McLuskey, K | 1 |
3 other study(ies) available for quinazolines and 2,4,6-triamino-5-chloroquinazoline
| Article | Year |
|---|---|
Inhibition of dihydrofolate reductase. Structure-activity correlations of quinazolines.
Topics: Binding Sites; Folic Acid Antagonists; Liver; Molecular Conformation; Quinazolines; Structure-Activity Relationship | 1976 |
Crystallographic and molecular-orbital studies on the geometry of antifolate drugs.
Topics: Chemical Phenomena; Chemistry; Crystallography; Folic Acid Antagonists; Proguanil; Pyrimidines; Quinazolines; Triazines | 1980 |
Inhibition of Leishmania major pteridine reductase by 2,4,6-triaminoquinazoline: structure of the NADPH ternary complex.
Topics: Animals; Binding Sites; Crystallography, X-Ray; Electrons; Enzyme Inhibitors; Hydrogen Bonding; Leishmania major; Methotrexate; Models, Chemical; Models, Molecular; NADP; Oxidoreductases; Protein Conformation; Quinazolines | 2004 |